Drug and Therapeutics Bulletin 1996;34:25-27; doi:10.1136/dtb.1996.34425
Copyright © 1996 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Pre-conception, pregnancy and prescribing

The thalidomide tragedy in the early 1960s demonstrated the extent of the damage that drugs can do to the fetus. The episode led to the introduction of licensing arrangements controlling manufacture, sale, supply and marketing of drugs¹ and it is now rare for a licence application for a new drug to include a recommendation for its use in pregnancy. The British National Formulary warns that "no drug is safe beyond all doubt in early pregnancy". Pregnant women nonetheless may need drug treatment. In this article we consider what precautions the prescriber should take to ensure that the risk to the fetus is minimised while not denying women of child-bearing age effective therapy.